Caspofungin-resistant oral and esophageal candidiasis in a patient with AIDS [5]

AIDS

Volumn 21, Issue 1, 2007, Pages 118-119

  Jokela, Janet A ^a   Kaur, Preeti ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; CANDIDA ALBICANS; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG TOLERANCE; ESOPHAGUS CANDIDIASIS; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CANDIDA ALBICANS; CANDIDIASIS; CANDIDIASIS, ORAL; DRUG RESISTANCE, FUNGAL; ESOPHAGEAL DISEASES; HUMANS; MALE; PEPTIDES, CYCLIC;

EID: 33845479477     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280117f5f     Document Type: Letter

References (8)

1. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30 (Suppl. 1):5-14.
2. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97:339-346.
3. Fitchenbaum CJ, Koletar S, Yiannoutsos C, Holland F, Pottage J, Cohn SE, et al. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis 2000; 30:749-756.
4. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh JJ, Edwards JE. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-189.
5. Kartosonis NA, DiNubile MJ, Bartizal K, Hicks PS, Ryan D, Sable CA. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole. J Acquir Immune Defic Syndr 2002; 31:183-187.
6. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J Clin Microbiol 2003; 41:5729-5731.
7. Hernandez S, Lopez-Ribot JL, Najvar LK, McCarthy DI, Bocanegra R, Graybill JR. Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive candida esophagitis. Antimicrob Agents Chemother 2004; 48:1382-1383.
8. Kartsonis NA, Killar J, Mixson L, Hoe CH, Sable C, Bartizal K, Motyl M. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrob Agents Chemother 2005; 49:3616-3623.